{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:15:25Z","timestamp":1783422925259,"version":"3.54.6"},"reference-count":65,"publisher":"American Association for Cancer Research (AACR)","issue":"3","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010897","name":"Newton Fund","doi-asserted-by":"publisher","award":["Newton Fund Impact Scheme (536988100)"],"award-info":[{"award-number":["Newton Fund Impact Scheme (536988100)"]}],"id":[{"id":"10.13039\/100010897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Nasopharyngeal carcinoma (NPC), a cancer that is etiologically associated with the Epstein-Barr virus (EBV), is endemic in Southern China and Southeast Asia. The scarcity of representative NPC cell lines owing to the frequent loss of EBV episomes following prolonged propagation and compromised authenticity of previous models underscores the critical need for new EBV-positive NPC models. Herein, we describe the establishment of a new EBV-positive NPC cell line, designated NPC268 from a primary non-keratinizing, differentiated NPC tissue. NPC268 can undergo productive lytic reactivation of EBV and is highly tumorigenic in immunodeficient mice. Whole-genome sequencing revealed close similarities with the tissue of origin, including large chromosomal rearrangements, while whole-genome bisulfite sequencing and RNA sequencing demonstrated a hypomethylated genome and enrichment in immune-related pathways, respectively. Drug screening of NPC268 together with six other NPC cell lines using 339 compounds, representing the largest high-throughput drug testing in NPC, revealed biomarkers associated with specific drug classes. NPC268 represents the first and only available EBV-positive non-keratinizing differentiated NPC model, and extensive genomic, methylomic, transcriptomic, and drug response data should facilitate research in EBV and NPC, where current models are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>NPC268 is the first and only EBV-positive cell line derived from a primary non-keratinizing, differentiated nasopharyngeal carcinoma, an understudied but important subtype in Southeast Asian countries. This model adds to the limited number of authentic EBV-positive lines globally that will facilitate mechanistic studies and drug development for NPC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-23-0341","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T10:17:30Z","timestamp":1707992250000},"page":"645-659","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Establishment and Characterization of an Epstein-Barr Virus\u2013positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-6050","authenticated-orcid":true,"given":"Annie Wai Yeeng","family":"Chai","sequence":"first","affiliation":[{"name":"1Translational Cancer Biology Research Unit, Cancer Research Malaysia, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9858-1817","authenticated-orcid":true,"given":"Shi Mun","family":"Yee","sequence":"additional","affiliation":[{"name":"1Translational Cancer Biology Research Unit, Cancer Research Malaysia, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3542-2639","authenticated-orcid":true,"given":"Hui Mei","family":"Lee","sequence":"additional","affiliation":[{"name":"1Translational Cancer Biology Research Unit, Cancer Research Malaysia, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8137-2399","authenticated-orcid":true,"given":"Norazlin","family":"Abdul Aziz","sequence":"additional","affiliation":[{"name":"2Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health, Malaysia."},{"name":"3Faculty of Medicine, Universiti Teknologi MARA, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6548-2149","authenticated-orcid":true,"given":"Pei San","family":"Yee","sequence":"additional","affiliation":[{"name":"1Translational Cancer Biology Research Unit, Cancer Research Malaysia, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6992-8590","authenticated-orcid":true,"given":"Marini","family":"Marzuki","sequence":"additional","affiliation":[{"name":"2Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4042-7529","authenticated-orcid":true,"given":"Ka Wo","family":"Wong","sequence":"additional","affiliation":[{"name":"4Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-5325","authenticated-orcid":true,"given":"Alan K.S.","family":"Chiang","sequence":"additional","affiliation":[{"name":"4Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7448-5811","authenticated-orcid":true,"given":"Larry Ka-Yue","family":"Chow","sequence":"additional","affiliation":[{"name":"5Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5558-0685","authenticated-orcid":true,"given":"Wei","family":"Dai","sequence":"additional","affiliation":[{"name":"5Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8686-1749","authenticated-orcid":true,"given":"Teng Fei","family":"Liu","sequence":"additional","affiliation":[{"name":"6School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-2462","authenticated-orcid":true,"given":"Lu Ping","family":"Tan","sequence":"additional","affiliation":[{"name":"2Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8268-5271","authenticated-orcid":true,"given":"Alan Soo Beng","family":"Khoo","sequence":"additional","affiliation":[{"name":"2Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health, Malaysia."},{"name":"7Institute for Research, Development and Innovation and School of Postgraduate Studies, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia."},{"name":"8Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3488-6124","authenticated-orcid":true,"given":"Kwok Wai","family":"Lo","sequence":"additional","affiliation":[{"name":"9Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6571-3682","authenticated-orcid":true,"given":"Paul V.H.","family":"Lim","sequence":"additional","affiliation":[{"name":"10Tung Shin Hospital, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9199-1940","authenticated-orcid":true,"given":"Pathmanathan","family":"Rajadurai","sequence":"additional","affiliation":[{"name":"11Subang Jaya Medical Centre, Malaysia."},{"name":"12Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2082-9986","authenticated-orcid":true,"given":"Howard","family":"Lightfoot","sequence":"additional","affiliation":[{"name":"13Wellcome Sanger Institute, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5155-0646","authenticated-orcid":true,"given":"Syd","family":"Barthorpe","sequence":"additional","affiliation":[{"name":"13Wellcome Sanger Institute, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2618-4237","authenticated-orcid":true,"given":"Mathew J.","family":"Garnett","sequence":"additional","affiliation":[{"name":"13Wellcome Sanger Institute, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6765-9542","authenticated-orcid":true,"given":"Sok Ching","family":"Cheong","sequence":"additional","affiliation":[{"name":"1Translational Cancer Biology Research Unit, Cancer Research Malaysia, Malaysia."},{"name":"14Department of Oral and Maxillofacial Clinical Sciences, Faculty of Dentistry, University of Malaya, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"2024030421191927300_bib1","article-title":"Global cancer observatory: cancer today","author":"Ferlay","year":"2020"},{"key":"2024030421191927300_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3892\/ol.2021.12775","article-title":"Nasopharyngeal carcinoma among the Bidayuh of Sarawak, Malaysia: history and risk factors","volume":"22","author":"Linton","year":"2021","journal-title":"Oncol Lett"},{"key":"2024030421191927300_bib3","article-title":"Malaysia National Cancer Registry Report 2012\u201316","author":"Azizah","year":"2019"},{"key":"2024030421191927300_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21315\/mjms2021.28.1.9","article-title":"The incidence of nasopharyngeal carcinoma in Pahang State of Malaysia from 2012 to 2017","volume":"28","author":"Ahmad","year":"2021","journal-title":"Malays J Med Sci"},{"key":"2024030421191927300_bib5","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.31557\/APJCP.2019.20.6.1701","article-title":"Retrospective analysis of cancer care performance and survival outcome for nasopharyngeal carcinoma at a leading cancer treatment centre in Malaysia 2008\u20132012","volume":"20","author":"Abdullah","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"key":"2024030421191927300_bib6","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The enigmatic epidemiology of nasopharyngeal carcinoma","volume":"15","author":"Chang","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2024030421191927300_bib7","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.7314\/APJCP.2014.15.15.6455","article-title":"Five-year survival and median survival time of nasopharyngeal carcinoma in Hospital Universiti Sains Malaysia","volume":"15","author":"Siti-Azrin","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"2024030421191927300_bib8","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.31557\/APJCP.2020.21.11.3291","article-title":"Subtype specific nasopharyngeal carcinoma incidence and survival trends: differences between endemic and non-endemic populations","volume":"21","author":"Argirion","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"2024030421191927300_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cncr.32517","article-title":"Increasing incidence of Epstein-Barr virus\u2013related nasopharyngeal carcinoma in the United States","volume":"126","author":"Argirion","year":"2020","journal-title":"Cancer"},{"key":"2024030421191927300_bib10","first-page":"581","article-title":"Epstein-Barr virus and nasopharyngeal carcinoma","volume":"33","author":"Young","year":"2014","journal-title":"Chin J Cancer"},{"key":"2024030421191927300_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.4448","article-title":"The role of Epstein-Barr virus in epithelial malignancies","volume":"235","author":"Tsao","year":"2015","journal-title":"J Pathol"},{"key":"2024030421191927300_bib12","doi-asserted-by":"crossref","first-page":"20160270","DOI":"10.1098\/rstb.2016.0270","article-title":"Epstein-Barr virus infection and nasopharyngeal carcinoma","volume":"372","author":"Tsao","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2024030421191927300_bib13","doi-asserted-by":"crossref","first-page":"629780","DOI":"10.3389\/fonc.2021.629780","article-title":"The Impact of Epstein-Barr virus infection on epigenetic regulation of host cell gene expression in epithelial and lymphocytic malignancies","volume":"11","author":"Leong","year":"2021","journal-title":"Front Oncol"},{"key":"2024030421191927300_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.semcancer.2011.12.007","article-title":"Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis","volume":"22","author":"Takada","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"2024030421191927300_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcancer.2012.01.004","article-title":"The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)","volume":"22","author":"Dawson","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"2024030421191927300_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.semcancer.2011.12.002","article-title":"Role of EBNA1 in NPC tumourigenesis","volume":"22","author":"Frappier","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"2024030421191927300_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2011.12.001","article-title":"The role of miRNAs and EBV BARTs in NPC","volume":"22","author":"Marquitz","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"2024030421191927300_bib18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3389\/fonc.2020.00600","article-title":"Targeting Epstein-Barr virus in nasopharyngeal carcinoma","volume":"10","author":"Hau","year":"2020","journal-title":"Front Oncol"},{"key":"2024030421191927300_bib19","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00432-015-1969-3","article-title":"Epstein\u2013Barr virus-targeted therapy in nasopharyngeal carcinoma","volume":"141","author":"Stoker","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"2024030421191927300_bib20","doi-asserted-by":"crossref","first-page":"eaau5612","DOI":"10.1126\/scitranslmed.aau5612","article-title":"Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth","volume":"11","author":"Messick","year":"2019","journal-title":"Sci Transl Med"},{"key":"2024030421191927300_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","article-title":"Regulation of the latent-lytic switch in Epstein\u2013Barr virus","volume":"26","author":"Kenney","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"2024030421191927300_bib22","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/ijc.27439","article-title":"Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma","volume":"131","author":"Hui","year":"2012","journal-title":"Int J Cancer"},{"key":"2024030421191927300_bib23","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-018-06889-5","article-title":"Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma","volume":"9","author":"Lin","year":"2018","journal-title":"Nat Commun"},{"key":"2024030421191927300_bib24","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/ijc.23374","article-title":"Authentication of nasopharyngeal carcinoma tumor lines","volume":"122","author":"Chan","year":"2008","journal-title":"Int J Cancer"},{"key":"2024030421191927300_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F","article-title":"Nasopharyngeal carcinoma cell line (C666\u20131) consistently harbouring Epstein-Barr virus","volume":"83","author":"Cheung","year":"1999","journal-title":"Int J Cancer"},{"key":"2024030421191927300_bib26","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41374-018-0034-7","article-title":"Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation","volume":"98","author":"Yip","year":"2018","journal-title":"Lab Invest"},{"key":"2024030421191927300_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nprot.2016.174","article-title":"Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens","volume":"12","author":"Liu","year":"2017","journal-title":"Nat Protoc"},{"key":"2024030421191927300_bib28","first-page":"453","article-title":"Establishment and characterization of Asian oral cancer cell lines as in vitro models to study a disease prevalent in Asia","volume":"19","author":"Hamid","year":"2007","journal-title":"Int J Mol Med"},{"key":"2024030421191927300_bib29","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.1038\/s41598-017-12045-8","article-title":"CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma","volume":"7","author":"Hoe","year":"2017","journal-title":"Sci Rep"},{"key":"2024030421191927300_bib30","doi-asserted-by":"crossref","first-page":"e57761","DOI":"10.7554\/eLife.57761","article-title":"Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway","volume":"9","author":"Chai","year":"2020","journal-title":"eLife"},{"key":"2024030421191927300_bib31","first-page":"1188","article-title":"Quantitative analysis of cell-free Epstein-Barr Virus DNA in plasma of patients with nasopharyngeal carcinoma","volume":"59","author":"Lo","year":"1999","journal-title":"Cancer Res"},{"key":"2024030421191927300_bib32","doi-asserted-by":"crossref","first-page":"E3473","DOI":"10.1073\/pnas.1202637109","article-title":"Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells","volume":"109","author":"Tsang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024030421191927300_bib33","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/ijc.32049","article-title":"High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma","volume":"144","author":"Hui","year":"2019","journal-title":"Int J Cancer"},{"key":"2024030421191927300_bib34","doi-asserted-by":"crossref","first-page":"104357","DOI":"10.1016\/j.ebiom.2022.104357","article-title":"Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma","volume":"86","author":"Ka-Yue Chow","year":"2022","journal-title":"EBioMedicine"},{"key":"2024030421191927300_bib35","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/gb-2012-13-10-r87","article-title":"methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles","volume":"13","author":"Akalin","year":"2012","journal-title":"Genome Biol"},{"key":"2024030421191927300_bib36","first-page":"005991","article-title":"iRAP \u2013 an integrated RNA-seq analysis pipeline","author":"Fonseca","year":"2014","journal-title":"bioRxiv"},{"key":"2024030421191927300_bib37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat Genet"},{"key":"2024030421191927300_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2004.01.035","article-title":"V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma","volume":"211","author":"Zhang","year":"2004","journal-title":"Cancer Lett"},{"key":"2024030421191927300_bib39","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/jmv.21503","article-title":"The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma","volume":"81","author":"Li","year":"2009","journal-title":"J Med Virol"},{"key":"2024030421191927300_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13643-015-0037-z","article-title":"The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies","volume":"4","author":"da Costa","year":"2015","journal-title":"Syst Rev"},{"key":"2024030421191927300_bib41","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/JVI.78.2.868-881.2004","article-title":"Potential selection of LMP1 variants in nasopharyngeal carcinoma","volume":"78","author":"Edwards","year":"2004","journal-title":"J Virol"},{"key":"2024030421191927300_bib42","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/jnci\/94.23.1757","article-title":"Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr Virus","volume":"94","author":"Gutie\u0301rrez","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"2024030421191927300_bib43","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/jnci\/95.13.1008","article-title":"Re: discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus","volume":"95","author":"Tong","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2024030421191927300_bib44","doi-asserted-by":"crossref","first-page":"e1007179","DOI":"10.1371\/journal.ppat.1007179","article-title":"A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection","volume":"14","author":"Bristol","year":"2018","journal-title":"PLoS Pathog"},{"key":"2024030421191927300_bib45","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41588-019-0436-5","article-title":"Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma","volume":"51","author":"Xu","year":"2019","journal-title":"Nat Genet"},{"key":"2024030421191927300_bib46","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s40880-015-0073-z","article-title":"A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma","volume":"34","author":"Feng","year":"2015","journal-title":"Chin J Cancer"},{"key":"2024030421191927300_bib47","first-page":"1355","article-title":"Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia","volume":"146","author":"Pathmanathan","year":"1995","journal-title":"Am J Pathol"},{"key":"2024030421191927300_bib48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.7150\/jca.13150","article-title":"Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666\u20131 and Raji cells","volume":"7","author":"Xiao","year":"2016","journal-title":"J Cancer"},{"key":"2024030421191927300_bib49","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1093\/nar\/gku525","article-title":"The elusive evidence for chromothripsis","volume":"42","author":"Kinsella","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2024030421191927300_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"2024030421191927300_bib51","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1200\/JCO.2017.73.0143","article-title":"AKT inhibition in solid tumors with AKT1 mutations","volume":"35","author":"Hyman","year":"2017","journal-title":"J Clin Oncol"},{"key":"2024030421191927300_bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jamaoncol.2020.6741","article-title":"Effect of capivasertib in patients with an AKT1 E17K-mutated tumor: NCI-MATCH subprotocol EAY131-Y nonrandomized trial","volume":"7","author":"Kalinsky","year":"2021","journal-title":"JAMA Oncol"},{"key":"2024030421191927300_bib53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semcancer.2019.09.006","article-title":"Translational genomics of nasopharyngeal cancer","volume":"61","author":"Tsang","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"2024030421191927300_bib54","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.1073\/pnas.1607606113","article-title":"Whole-exome sequencing identifies multiple loss-of-function mutations of NF-\u03baB pathway regulators in nasopharyngeal carcinoma","volume":"113","author":"Zheng","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024030421191927300_bib55","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1038\/s41467-021-24348-6","article-title":"Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-\u03baB activation and immune escape","volume":"12","author":"Bruce","year":"2021","journal-title":"Nat Commun"},{"key":"2024030421191927300_bib56","doi-asserted-by":"crossref","first-page":"e2115999119","DOI":"10.1073\/pnas.2115999119","article-title":"LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint","volume":"119","author":"McKerrow","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024030421191927300_bib57","doi-asserted-by":"crossref","first-page":"110649","DOI":"10.1016\/j.biopha.2020.110649","article-title":"Anti-EGFR therapies in nasopharyngeal carcinoma","volume":"131","author":"Chen","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"2024030421191927300_bib58","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3892\/or.2014.3376","article-title":"Hotspot mutations in common oncogenes are infrequent in nasopharyngeal carcinoma","volume":"32","author":"Jiang","year":"2014","journal-title":"Oncol Rep"},{"key":"2024030421191927300_bib59","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1158\/1535-7163.MCT-15-0230","article-title":"Tumors with AKT1E17K mutations are rational targets for single agent or combination therapy with AKT inhibitors","volume":"14","author":"Davies","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"2024030421191927300_bib60","doi-asserted-by":"crossref","first-page":"e0140479","DOI":"10.1371\/journal.pone.0140479","article-title":"Targeting AKT1-E17K and the PI3K\/AKT Pathway with an allosteric AKT Inhibitor, ARQ 092","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS One"},{"key":"2024030421191927300_bib61","doi-asserted-by":"crossref","first-page":"768","DOI":"10.21037\/atm.2019.11.75","article-title":"The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up","volume":"7","author":"Wu","year":"2019","journal-title":"Ann Transl Med"},{"key":"2024030421191927300_bib62","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1128\/JVI.00135-06","article-title":"LMP1 strain variants: biological and molecular properties","volume":"80","author":"Mainou","year":"2006","journal-title":"J Virol"},{"key":"2024030421191927300_bib63","first-page":"2021.11.08.467751","article-title":"Chromosome breaks in breast cancers occur near herpes tumor virus sequences and explain why the cancer comes back","author":"Friedenson","year":"2022","journal-title":"bioRxiv"},{"key":"2024030421191927300_bib64","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1038\/s41598-020-66678-3","article-title":"The prognostic value of deficient mismatch repair in stage II-IVa nasopharyngeal carcinoma in the era of IMRT","volume":"10","author":"Chen","year":"2020","journal-title":"Sci Rep"},{"key":"2024030421191927300_bib65","doi-asserted-by":"crossref","first-page":"e20210108","DOI":"10.1084\/jem.20210108","article-title":"Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN-driven CCL5 and CXCL10","volume":"218","author":"Mowat","year":"2021","journal-title":"J Exp Med"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-23-0341\/3415715\/crc-23-0341.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/3\/645\/3421593\/crc-23-0341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/3\/645\/3421593\/crc-23-0341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T09:15:17Z","timestamp":1731316517000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/3\/645\/735042\/Establishment-and-Characterization-of-an-Epstein"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,4]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0341","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.25338647.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338653.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338644.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338638.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338662.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338635.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338650","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338629.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338644","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338632","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28777730","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338632.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338626","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338614","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338626.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338656","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28777736","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28777724","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338638","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28777727","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338623.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28777739","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338614.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338617.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338659.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338641.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338611.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338611","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338665","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338653","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338641","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338659","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338656.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338647","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28777721","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338635","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338623","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28777733","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338629","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338650.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25338617","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7104599","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]}}}